The Use of Extended Platelet Rich Fibrin in Lateral Sinus Augmentation

ConditionSinus Lift Augmentation

Trial statusNot yet recruiting

Trial phaseNot applicable

Trial typeInterventional

Biological sexAll

Age20-60

SponsorMansoura University

About this trial

thirty implants will be inserted in patients seeking implantation of their lost posterior maxillary teeth (premolar and molars) with limited bone height below the floor of the maxillary sinus, secondary to sinus pneumatization. The patients will be selected from those attending the outpatient clinic of the Oral \& Maxillofacial Surgery Department, Faculty of Dentistry, Mansoura University.

1. Clinical Evaluation

• Implant stability 2. Radiographic Evaluation Vertical bone gain (VBG)

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

Patent ostium of maxillary sinus.

Patient with missing one or more posterior maxillary teeth.

Residual bone height of 3-6 mm, measured from the crest of alveolar ridge to the floor of the maxillary sinus at the planned implant site.

A ridge width at the site of implantation of <5mm.

Disqualifiers

Active sinusitis, cyst, tumors or root tips at the planned surgical site.

Patients with systemic diseases that contra-indicate the surgical procedure such as uncontrolled diabetes mellitus, bleeding disorders, serious osseous disorders, and mental disorders.

Heavy smoking and alcoholism.

Parafunctional habits such as bruxism and clenching.

Trial design

Design model

Parallel

Treatments tested in this trial

lateral sinus lift with using allograft and collagen membrane
Procedure/Surgery
sinus floor elevation with placing allograft and collagen membrane
lateral sinus lift with using exteneded platelet rich fibrin
Procedure/Surgery
sinus floor elevation with placing eprf

Treatment groups

30 Participants

are divided into 2 treatment groups

Group A: lateral sinus lift with bone augmenationExperimental treatment 1 intervention

Group B: lateral sinus lift with extended platelet rich fibrinExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

implant stability

the stability of the implants will be evaluated by RFA with the Osstell Mentor device.

Time frame

9 months

Vertical bone height

vertical bone height will be measured as the distance from the alveolar crest to the new sinus floor at the middle of the implant

Time frame

6 months

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Mansoura University

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: